You are here: Industry Insights > Cell Therapy

News List

FDA Approves Study to Investigate Cell Therapy to Treat COVID-19 Related MIS-C americanpharmaceuticalreview
September 23, 2020
The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with ...
T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy contractpharma
September 22, 2020
Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.
Takeda Opens R&D Cell Therapy Mfg. Facility in Boston contractpharma
September 16, 2020
Will support expansion of next-generation clinical programs, including five collaborative oncology cell therapy programs entering trials.
Sotio Acquires Rights to BOXR Cell Therapy Platform contractpharma
September 01, 2020
Sotio, a clinical stage immuno-oncology company owned by PPF Group, has acquired the rights to Unum Therapeutics’ BOXR cell therapy platform and BOXR lead programs to develop novel T cell therapies for the treatment of solid tumors.
India gives nod to cell therapy for Critical Limb Ischemia (CLI) europeanpharmaceuticalreview
August 25, 2020
Stempeucel®, a cell therapy for the treatment of Critical Limb Ischemia (CLI), has been approved for commercial use in India by the Drug Controller General.
Orca Bio raises $192m to support cell therapies development pharmaceutical-technology
June 19, 2020
US-based biotechnology firm Orca Bio has raised $192m in a Series D financing round to support the development of cell therapies intended to provide an alternative for standard bone marrow transplants.
Lineage Cell Therapeutics to apply allogeneic dendritic cell therapy programme to Covid-19 vaccine d pharmaceutical-business-review
May 08, 2020
Lineage Cell Therapeutics, a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.
RoosterBio, Senti Biosciences Partner on Cell Therapy contractpharma
March 23, 2020
Collaboration leverages cGMP clinical systems to accelerate gene modified cell therapy for solid tumors.
Cellenkos to trial cell therapy for CoV-ARDS pharmaceutical-technology
March 19, 2020
Cellenkos has filed a proposal with the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase I / II clinical trial of CK0802 to treat Covid-19 ...
Charles River Laboratories to acquire HemaCare for $380m pharmaceutical-technology
December 18, 2019
Charles River Laboratories International has signed a definitive agreement to acquire cellular products developer HemaCare for a cash consideration of approximately $380m.

Previous page 1 2 3 4 5 6 7 8 Next page